Windtree Therapeutics (NASDAQ: WINT) shares are surging on Wednesday after the company was granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure".
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 200 points on Friday.
The Dow traded up 0.61% to 33,245.17 while the NASDAQ rose 2.14% to 11,084.83. The S&P 500 also rose, gaining, 1.24% to 3,947.25.
Gainers
Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.